RGEN - REPLIGEN CORP
125.84
2.780 2.209%
Share volume: 666,470
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$123.06
2.78
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2024 | 07-30-2024 | 11-18-2024 | 03-13-2025 | 04-29-2025 | 08-07-2025 | 11-04-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 2.849 B | 2.862 B | 2.831 B | 2.830 B | 2.852 B | 2.902 B | 2.924 B | 2.950 B | |
| Current Assets | 1.133 B | 1.159 B | 1.132 B | 1.066 B | 1.032 B | 1.057 B | 1.096 B | 1.137 B | |
| Inventories | 198.033 M | 190.528 M | 182.465 M | 142.964 M | 153.110 M | 155.862 M | 160.320 M | 170.458 M | |
| Other Current Assets | 37.586 M | 34.983 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 37.586 M | 34.983 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 201.607 M | |
| Total Receivables | 115.766 M | 123.245 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 780.617 M | 809.146 M | 783.964 M | 757.355 M | 697.229 M | 708.855 M | 748.747 M | 566.021 M | |
| Total Non-current Assets | 1.716 B | 1.703 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 205.716 M | 204.599 M | 202.583 M | 197.738 M | 195.519 M | 193.489 M | 188.927 M | 186.614 M | |
| Other Assets | 956.000 K | 853.000 K | 1.496 B | 1.566 B | 1.624 B | 1.651 B | 1.638 B | 1.626 B | |
| Intangible Assets | 388.146 M | 379.813 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 985.963 M | 985.613 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.849 B | 2.862 B | 2.831 B | 2.830 B | 2.852 B | 2.902 B | 2.924 B | 2.950 B | |
| Total liabilities | 878.668 M | 875.562 M | 813.958 M | 856.948 M | 866.660 M | 839.886 M | 840.624 M | 843.570 M | |
| Total current liabilities | 178.315 M | 174.307 M | 108.366 M | 126.787 M | 151.996 M | 123.012 M | 131.136 M | 135.826 M | |
| Accounts Payable | 18.731 M | 20.910 M | 21.357 M | 32.134 M | 26.935 M | 25.625 M | 29.426 M | 30.010 M | |
| Other liabilities | 3.646 M | 3.707 M | 150.299 M | 181.819 M | 160.923 M | 159.823 M | 151.426 M | 143.035 M | |
| Current long term debt | 69.480 M | 69.481 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 513.918 M | 517.725 M | 521.607 M | 525.567 M | 529.605 M | 533.725 M | 537.927 M | 542.213 M | |
| Other liabilities | 3.646 M | 3.707 M | 150.299 M | 181.819 M | 160.923 M | 159.823 M | 151.426 M | 143.035 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.971 B | 1.986 B | 2.017 B | 1.973 B | 1.985 B | 2.062 B | 2.083 B | 2.106 B | |
| Common stock | 55.791 M | 55.884 M | 1.610 B | 1.618 B | 1.620 B | 1.635 B | 1.644 B | 1.652 B | |
| Retained earnings | 440.943 M | 444.264 M | 441.223 M | 407.354 M | 413.184 M | 428.050 M | 442.961 M | 456.248 M |